Unexpected Synthesis of an Unsymmetrical μ-Oxido Divanadium(V) Compound through a Reductive Cleavage of a N−O Bond and Cleavage-Hydrolysis of a C−N Bond of an N,N-Disubstituted Bis-(hydroxylamino) Ligand

Exploring the effect of substituent in the hydrazone ligand of a family of μ-oxidodivanadium(v) hydrazone complexes on structure, DNA binding and anticancer activity

The reaction of 2-hydroxybenzoylhydrazine (H₂bh) separately with equimolar amounts of [V^IVO(aa)₂] and [V^IVO(ba)₂] in CHCl₃ afforded the complexes [VO₃(HL¹)₂] (1) and [VO₃(HL²)₂] (2) respectively in good to excellent yield ((HL¹)^2- and (HL²)^2- represent respectively the dianionic form of 2-hydroxybenzoylhydrazones of acetylacetone (H₃L¹) and benzoylacetone (H₃L²) (general abbreviation H₃L)). From X-ray structure analysis, the V^V-O-V^V angle was found to be ∼115° and 180° in 1 and 2 respectively. Upon one-electron reduction selectively at one V centre at an appropriate potential, each of 1 and 2 generated mixed-valence [(HL)V^VO-(μ-O)-OV^IV(HL)]^- species 1A and 2A respectively, which showed valence delocalization at room temperature and localization at 77 K, and the V^IV-O-V^V bond angles were calculated to be 177.5° and 180° respectively. The intercalative mode of binding of the two complexes 1 and 2 with CT DNA has been suggested by UV-visible spectroscopy (K_b = 7.31 × 10⁵ M^-1 and 8.71 × 10⁵ M^-1 respectively for 1 and 2), fluorescence spectroscopy (K_sv = 6.85 × 10⁵ M^-1 and 8.53 × 10⁵ M^-1 respectively for 1 and 2) and circular dichroism spectroscopy. Such intercalative mode of binding of these two complexes with CT DNA and HPV DNA has also been confirmed by molecular docking study. Both complexes 1 and 2 exhibited promising anti-cancer activity against SiHa cervical cancer cells with IC₅₀ values of 28 ± 0.5 μM and 25 ± 0.5 μM respectively for 24 h which is significantly better than that of widely used cisplatin (with IC₅₀ value of 63.5 μM). Nuclear staining experiments reveal that these complexes kill the SiHa cells through apoptotic mode. It is interesting to note that these two complexes are non-toxic to normal T293 cell line. Complex 2 showed higher DNA binding ability with CT DNA and HPV DNA as well as better anti-cancer properties towards SiHa cervical cancer cells in comparison to complex 1, a fact which can be explained by considering the lower energy of LUMO (which favours electron transition from DNA to the metal complex) and also the higher surface area of complex 2 in comparison to complex 1 due to the presence of one extra electron-withdrawing phenyl group in the former.

Interaction of chromium(III) with a N,N'-disubstituted hydroxylamine-(diamido) ligand: a combined experimental and theoretical study

Reaction of hydroxylamine hydrochloride with prop-2-enamide in dichloromethane in the presence of triethylamine resulted in the isolation of the N,N'-disubstituted hydroxylamine-(diamido) ligand, 3,3'-(hydroxyazanediyl)dipropanamide (Hhydia). The ligand Hhydia was characterized by multinuclear NMR, high-resolution electrospray ionization mass spectrometry (ESI-MS), and X-ray structure analysis. Interaction of Hhydia with trans-[Cr(III)Cl2(H2O)4]Cl·2H2O in ethanol yields the ionization isomers [Cr(III)(Hhydia)2]Cl3·2H2O(1·2H2O) and cis/trans-[Cr(III)Cl2(Hhydia)2]Cl·2H2O (2·2H2O). The X-ray structure analysis of 1 revealed that the chromium atom in [Cr(III)(Hhydia)2](3+) is bonded to two neutral tridentate O,N,O-Hhydia ligands. The twist angle, θ, in [Cr(III)(Hhydia)2](3+) is 54.5(6)(0), that is, very close to an ideal octahedron. The intramolecular hydrogen bonds developed between the N-OH group of the first ligand and the amidic oxygen atom of the second ligand and vice versa contribute to the overall stability of the cation [Cr(III)(Hhydia)2](3+). The reaction rate constant of the formation of Cr(III) complexes 1·2H2O and 2·2H2O was found to be 8.7(±0.8) × 10(-5) M(-1) s(-1) at 25 °C in methyl alcohol and follows a first-order law kinetics based on the biologically relevant ligand Hhydia. The reaction rate constant is considerably faster in comparison with the corresponding water exchange rate constant for the hydrated chromium(III). The modification of the kinetics is of fundamental importance for the chromium(III) chemistry in biological systems. Ultraviolet-visible and electron paramagnetic resonance studies, both in solution and in the solid state, ESI-MS, and conductivity measurements support the fact that, irrespective of the solvent used in the interaction of Hhydia with trans-[Cr(III)Cl2(H2O)4]Cl·2H2O, the ionization isomers[Cr(III)(Hhydia)2]Cl3·2H2O (1·2H2O) and cis/trans-[Cr(III)Cl2(Hhydia)2]Cl·2H2O (2·2H2O) are produced.The reaction medium affects only the relevant percentage of the isomers in the solid state. The thermodynamic stability of the ionization isomers 1·2H2O and cis/trans-2·2H2O, their molecular structures as well as the vibrational spectra and the energetics of the Cr(III)- Hhydia/hydia(-) were studied by means of density functional theory calculations and found to be in excellent agreement with our experimental observations.

Heterobimetallic μ-oxido complexes containing discrete V(V)-O-M(III) (M = Mn, Fe) cores: targeted synthesis, structural characterization, and redox studies

Heterobimetallic compounds [L'OV(V)(μ-O)M(III)L]n (n = 1, M = Mn, 1-5; n = 2, M = Fe, 6 and 7) containing a discrete unsupported V(V)-O-M(III) bridge have been synthesized through a targeted synthesis route. In the V-O-Mn-type complexes, the vanadium(V) centers have a square-pyramidal geometry, completed by a dithiocarbazate-based tridentate Schiff-base ligand (H2L'), while the manganese(III) centers have either a square-pyramidal (1 and 3) or an octahedral (2 and 5) geometry, made up of a Salen-type tetradentate ligand (H2L) as established by X-ray diffraction analysis. The V-O-Mn bridge angle in these compounds varies systematically from 155.3° to 128.1° in going from 1 to 5 while the corresponding dihedral angle between the basal planes around the metal centers changes from 86.82° to 20.92°, respectively. The V-O-Fe-type complexes (6 and 7) are tetranuclear, in which the two dinuclear V(μ-O)Fe units are connected together by apical iron(III)-aryl oxide interactions, forming a dimeric structure with a pair of Fe-O-Fe bridges. The X-ray data also confirm the V═O → M canonical form to contribute predominantly on the overall V-O-M bridge structure. The molecules in solution also retain their heterobinuclear composition, as established by electrospray ionization mass spectrometry and (51)V NMR spectroscopy. Electrochemically, these complexes are quite interesting; the manganese(III) complexes (1-5) display three successive reductions (processes I-III), each with a monoelectron stoichiometry. Process I is due to a Mn(III)/Mn(II) reduction (E1/2 ranges between -0.32 and -0.05 V), process II is a ligand-based reduction, and process III (E1/2 = ∼1.80 V) owes its origin to a V(V)O/V(IV)O reduction; all potentials are versus Ag/AgCl. The iron(III) compounds (6 and 7), on the other hand, show at least four irreversible processes, appearing at Epc = -0.20, -1.0, -1.58, and -1.68 V in compound 6 (processes IV-VII), together with a reversible process (process VIII) at E1/2 = -1.80 V (ΔEp = 80 mV). While the first two of these are due to Fe(III)/Fe(II) reductions at the two iron(III) centers of these tetranuclear cores, the reversible reduction at a more negative potential (ca. -1.80 V) is due to a V(V)O/V(IV)O-based electron transfer.

Ligand substitution reactions of a phenolic quinolyl hydrazone; oxidovanadium (IV) complexes

BACKGROUND

Quinoline ring has therapeutic and biological activities. Quinolyl hydrazones constitute a class of excellent chelating agents. Recently, the physiological and biological activities of quinolyl hydrazones arise from their tendency to form metal chelates with transition metal ions. In this context, we have aimed to study the competency effect of a phenolic quinolyl hydrazone (H2L; primary ligand) with some auxiliary ligands (Tmen, Phen or Oxine; secondary ligands) towards oxidovanadium (IV) ions.

RESULTS

Mono- and binuclear oxidovanadium (IV) - complexes were obtained from the reaction of a phenolic quinolyl hydrazone with oxidovanadium (IV)- ion in absence and presence of N,N,N',N'- tetramethylethylenediamine (Tmen), 1,10-phenanthroline (Phen) or 8-hydroxyquinoline (Oxine). The phenolic quinolyl hydrazone ligand behaves as monobasic bidentate (NO- donor with O- bridging). All the obtained complexes have the preferable octahedral geometry except the oxinato complex (2) which has a square pyramid geometry with no axial interaction; the only homoleptic complex in this study.

CONCLUSION

The ligand exchange (substitution/replacement) reactions reflect the strong competency power of the auxiliary aromatic ligands (Phen/Oxine) compared to the phenolic quinolyl hydrazone (H2L) towards oxidovanadium (IV) ion; (complexes 2 and 3). By contrast, in case of the more flexible aliphatic competitor (Tmen), an adduct was obtained (4). The obtained complexes reflect the strength of the ligand field towards the oxidovanadium (IV)- ion; Oxine or Phen >> phenolic hydrazone (H2L) > Tmen.